Clarithromycin induced torsade de pointes

Irish Journal of Medical Science

Volumn 177, Issue 1, 2008, Pages 67-68

  Hensey, C ^a,b   Keane, D ^a  

^a ST VINCENT S UNIVERSITY HOSPITAL   (Ireland)

^b 14 Wilfield Park ^*  (Ireland)

Author keywords

Acquired; Clarithromycin; Medication; Prolongation; QT interval; Torsade de pointes

Indexed keywords

ANTIINFECTIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CLARITHROMYCIN;

AGED; ARTICLE; ARTIFICIAL HEART PACEMAKER; CASE REPORT; CHEMICALLY INDUCED DISORDER; ELECTROCARDIOGRAPHY; FEMALE; HUMAN; TORSADE DES POINTES;

ADRENERGIC BETA-ANTAGONISTS; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CLARITHROMYCIN; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; PACEMAKER, ARTIFICIAL; TORSADES DE POINTES;

EID: 50349101083     PISSN: 00211265     EISSN: 18634362     Source Type: Journal    
DOI: 10.1007/s11845-007-0057-3     Document Type: Article

References (6)

1. Makkar R, Fromm B, Steinman R et al (1993) Female gender as a risk factor for torsade de pointes associated with cardiovascular drugs. JAMA 270:2590-2597
2. Hohnloser SH, Klingenheben T, Singh BN (1994) Amiodarone-associated proarrhythmic effects. A review with special reference to torsades de pointes tachycardia. Ann Intern Med 121:529-535
3. Kurita T, Ohe T, Marui N, Aihara N, Takaki H, Kamakura S et al (1992) Bradycardia-induced abnormal QT prolongation in patients with complete atrioventricular block with torsade de pointes. Am J Cardiol 69:628-633
4. Irish Medicines Board, Pharmacovigilance Department (2006) http://www.imb.ie
5. Gitler B, Berger LS, Buffa SD (1994) Torsades de pointes induced by erythromycin. Chest 105:368-372
6. Priori SG, Napolitano C, Schwartz PJ (1999) Low penetrance in the long-QT syndrome: clinical impact. Circulation 99:529-533